Susquehanna International Group
SGMT icon

Susquehanna International Group’s Sagimet Biosciences SGMT Stock Holding History

Susquehanna International Group’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$651K Sell
124,604
-54,420
-30% -$303K ﹤0.01% 8984
2025
Q4 		$1.06M Buy
179,024
+146,463
+450% +$1.05M ﹤0.01% 7051
2025
Q3 		$223K Sell
32,561
-108,846
-77% -$883K ﹤0.01% 10749
2025
Q2 		$1.08M Sell
141,407
-45,939
-25% -$194K ﹤0.01% 7222
2025
Q1 		$611K Buy
187,346
+7,480
+4% +$31.4K ﹤0.01% 8463
2024
Q4 		$809K Buy
179,866
+20,931
+13% +$106K ﹤0.01% 7486
2024
Q3 		$440K Buy
158,935
+57,871
+57% +$178K ﹤0.01% 8778
2024
Q2 		$346K Buy
101,064
+73,141
+262% +$336K ﹤0.01% 9136
2024
Q1 		$151K Buy
+27,923
New +$201K ﹤0.01% 10899

Other funds holding SGMT

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Susquehanna International Group's SGMT Position: Q1 2026 in Review

Susquehanna International Group reduced its Sagimet Biosciences (SGMT) stake by 30% in Q1 2026, selling an estimated $303K and leaving 124,604 shares worth $651K. The position accounts for ﹤0.01% of the portfolio, ranked #8984.

Susquehanna International Group first reported a position in SGMT in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.08M in Q2 2025. 88 funds tracked by Wall St. Rank hold SGMT as of Q1 2026.

  • Susquehanna International Group held 124,604 shares of Sagimet Biosciences worth $651K as of Q1 2026.
  • Susquehanna International Group sold 54,420 Sagimet Biosciences shares in Q1 2026, an estimated $303K.
  • Sagimet Biosciences made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #8984 holding.
  • Susquehanna International Group first reported a position in Sagimet Biosciences in Q1 2024 and has held it in 9 quarters since.
  • Susquehanna International Group's Sagimet Biosciences position peaked at $1.08M in Q2 2025.
  • 88 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.